Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study

(1) Background: SARS-CoV-2 infection is notably mild in children, though comorbidities may increase the risk of hospitalization and may represent a risk for increased disease severity. There is an urgent need for targeted therapies with an acceptable efficacy and safety profile. To date, most of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Minotti, Chiara, Mengato, Daniele, De Pieri, Marica, Trivellato, Sabrina, Francavilla, Andrea, Di Chiara, Costanza, Liberati, Cecilia, Mattera, Raffaele, Biffi, Alessandra, Giaquinto, Carlo, Venturini, Francesca, Donà, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867507/
https://www.ncbi.nlm.nih.gov/pubmed/36680232
http://dx.doi.org/10.3390/v15010192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867507/
https://www.ncbi.nlm.nih.gov/pubmed/36680232
http://dx.doi.org/10.3390/v15010192

Ejemplares similares